A Mitochondrial Basis for Heart Failure Progression

被引:3
|
作者
Watson, William D. [1 ,2 ]
Arvidsson, Per M. [2 ,3 ,4 ]
Miller, Jack J. J. [2 ,5 ]
Lewis, Andrew J. [2 ]
Rider, Oliver J. [2 ]
机构
[1] Univ Cambridge, Div Cardiovasc Med, Cambridge, England
[2] Univ Oxford, Oxford Ctr Magnet Resonance Res, Oxford, England
[3] Lund Univ, Dept Clin Sci Lund, Clin Physiol, Lund, Sweden
[4] Skane Univ Hosp, Dept Clin Physiol, Lund, Sweden
[5] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
关键词
Heart failure; Mitochondria; Redox; Calcium; ATP; PERMEABILITY TRANSITION PORE; PRESSURE-VOLUME AREA; IN-VIVO P-31; CARDIAC-HYPERTROPHY; FAILING HEART; KINASE-II; OXIDATIVE-PHOSPHORYLATION; SARCOPLASMIC-RETICULUM; METABOLIC FLEXIBILITY; SYSTEM BIOENERGETICS;
D O I
10.1007/s10557-024-07582-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In health, the human heart is able to match ATP supply and demand perfectly. It requires 6 kg of ATP per day to satisfy demands of external work (mechanical force generation) and internal work (ion movements and basal metabolism). The heart is able to link supply with demand via direct responses to ADP and AMP concentrations but calcium concentrations within myocytes play a key role, signalling both inotropy, chronotropy and matched increases in ATP production. Calcium/calmodulin-dependent protein kinase (CaMKII) is a key adapter to increased workload, facilitating a greater and more rapid calcium concentration change. In the failing heart, this is dysfunctional and ATP supply is impaired. This review aims to examine the mechanisms and pathologies that link increased energy demand to this disrupted situation. We examine the roles of calcium loading, oxidative stress, mitochondrial structural abnormalities and damage-associated molecular patterns.
引用
收藏
页码:1161 / 1171
页数:11
相关论文
共 50 条
  • [41] Mitochondrial dysfunction in pathophysiology of heart failure
    Zhou, Bo
    Tian, Rong
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (09): : 3716 - 3726
  • [42] Depressed mitochondrial fusion in heart failure
    Chen, Le
    Knowlton, Anne A.
    CIRCULATION, 2007, 116 (16) : 259 - 259
  • [43] Progression of secondary mitral regurgitation: from heart failure to valvular heart failure
    Lancellotti, Patrizio
    Garbi, Madalina
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2018, 19 (06) : 613 - 614
  • [44] Physiological Basis for Contractile Dysfunction in Heart Failure
    Libera, Luciano Dalla
    Vescovo, Giorgio
    Volterrani, Maurizio
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (25) : 2572 - 2581
  • [45] Cellular basis for therapeutic choices in heart failure
    Opie, LH
    CIRCULATION, 2004, 110 (17) : 2559 - 2561
  • [46] Molecular basis of heart failure and dilated cardiomyopathy
    Osterziel, KJ
    Perrot, A
    HERZ, 2002, 27 (08) : 816 - 818
  • [47] PHARMACOLOGICAL BASIS OF THE THERAPY OF HEART-FAILURE
    HANNEDOUCHE, T
    SAOUDI, N
    PATHOLOGIE BIOLOGIE, 1987, 35 (04): : 391 - 397
  • [48] PHARMACOLOGICAL BASIS OF THE THERAPY OF HEART-FAILURE
    HANNEDOUCHE, T
    SAOUDI, N
    SEMAINE DES HOPITAUX, 1987, 63 (28): : 2324 - 2330
  • [49] BIOCHEMICAL BASIS OF HEART FUNCTION AND CONTRACTILE FAILURE
    DHALLA, NS
    DIXON, IMC
    BEAMISH, RE
    JOURNAL OF APPLIED CARDIOLOGY, 1991, 6 (01) : 7 - 30
  • [50] PATHOPHYSIOLOGIC BASIS OF THE THERAPY OF HEART-FAILURE
    ESCOBAR, E
    REVISTA MEDICA DE CHILE, 1981, 109 (01) : 47 - 53